XML 100 R90.htm IDEA: XBRL DOCUMENT v3.24.2.u1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Carrying Amount and Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other invested assets Other invested assets    
Financial assets        
Available-for-sale fixed maturity securities, at fair value $ 52,597 $ 18,777    
Equity securities 2,804 3,663    
Mortgage loans on real estate, net of allowance 12,444 5,962    
Policy loans 401 390    
Short-term investments 2,910 3,115    
Cash and cash equivalents 14,335 4,308    
Reinsurance funds withheld 1,573 7,248    
Other assets – market risk benefit assets 1,855 730    
Separate account assets 1,266 1,189    
Financial liabilities        
Policyholders’ account balances – embedded derivative 1,230 1,104    
Market risk benefits 3,276 89    
Separate account liabilities 1,266 1,189 $ 1,145 $ 1,045
Certain private equity measured at cost less any impairments   424    
Carrying Amount        
Financial assets        
Available-for-sale fixed maturity securities, at fair value 52,597 18,777    
Equity securities 2,804 3,663    
Mortgage loans on real estate, net of allowance 12,444 5,962    
Private loans, net of allowance 2,871 1,198    
Policy loans 401 390    
Short-term investments 2,910 3,115    
Derivative assets 1,620 342    
Separately managed accounts 89 105    
Other 900 58    
Cash and cash equivalents 14,335 4,308    
Reinsurance funds withheld 1,573 7,248    
Other assets – market risk benefit assets 704 34    
Separate account assets 1,266 1,189    
Total financial assets 94,514 46,389    
Financial liabilities        
Policyholders’ account balances – embedded derivative 1,196 1,104    
Market risk benefits 3,276 89    
Other liabilities – derivative liabilities 14 12    
Notes payable 657 174    
Corporate and subsidiary borrowings 4,461 3,569    
Separate account liabilities 1,266 1,189    
Total financial liabilities 10,870 6,137    
Carrying Amount | Recurring        
Financial assets        
Mortgage loans on real estate, net of allowance 12,444 5,962    
Private loans, net of allowance 2,871 1,198    
Policy loans 401 390    
Total financial assets 31,448 7,562    
Financial liabilities        
Corporate and subsidiary borrowings 4,461 3,569    
Total financial liabilities 83,795 25,370    
Fair Value        
Financial assets        
Available-for-sale fixed maturity securities, at fair value 52,597 18,777    
Equity securities 2,804 3,663    
Mortgage loans on real estate, net of allowance 12,228 5,683    
Private loans, net of allowance 2,871 855    
Policy loans 401 390    
Short-term investments 2,910 3,115    
Derivative assets 1,620 342    
Separately managed accounts 89 105    
Other 883 58    
Cash and cash equivalents 14,335 4,308    
Reinsurance funds withheld 1,573 7,248    
Other assets – market risk benefit assets 704 34    
Separate account assets 1,266 1,189    
Total financial assets 94,281 45,767    
Financial liabilities        
Policyholders’ account balances – embedded derivative 1,196 1,104    
Market risk benefits 3,276 89    
Other liabilities – derivative liabilities 14 12    
Notes payable 657 174    
Corporate and subsidiary borrowings 4,444 3,567    
Separate account liabilities 1,266 1,189    
Total financial liabilities 10,853 6,135    
Fair Value | Recurring        
Financial assets        
Mortgage loans on real estate, net of allowance 12,228 5,683    
Private loans, net of allowance 2,871 855    
Policy loans 401 390    
Total financial assets 30,150 6,940    
Financial liabilities        
Corporate and subsidiary borrowings 4,444 3,567    
Total financial liabilities 83,778 23,839    
Not subject to fair value hierarchy        
Financial assets        
Other 471 12    
Reinsurance funds withheld 1,500 7,300    
Separate account assets 32 26    
Financial liabilities        
Derivative asset, cash collateral $ 1,600 $ 209